Featured Research

from universities, journals, and other organizations

Suicide risk doesn't differ in children taking two types of commonly prescribed antidepressants

Date:
January 6, 2014
Source:
Vanderbilt University Medical Center
Summary:
A study released today shows there is no evidence that the risk of suicide differs with two commonly prescribed antidepressants prescribed to children and adolescents.

A Vanderbilt University Medical Center study released today shows there is no evidence that the risk of suicide differs with two commonly prescribed antidepressants prescribed to children and adolescents.

The population-based study, published today in the journal Pediatrics, tracked children and adolescents who recently began taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).

For the past decade parents and health care professionals have worried that children and adolescents treated with antidepressant medications might be at increased risk of suicidal thoughts or behavior.

In 2004 The U.S. Food and Drug Administration (FDA) and the UK Medicine Healthcare Products Regulatory Agency issued public warnings about the increased risk of suicidal thoughts or behavior in children and adolescents treated with certain antidepressant medications, and required that a boxed "black box" warning be added to package inserts for antidepressants.

Because antidepressants differ in their characteristics, including effects on neurotransmitters, it has also been believed that the risk of suicidal behavior for individual medications might differ.

"It is important to study this group of children and adolescents because many children are treated with these medications in the U.S. each year and we need to understand the differential risks for suicide attempts and completed suicides," said study author William Cooper, M.D., MPH, Cornelius Vanderbilt Professor of Pediatrics and professor of Health Policy.

SSRIs, like fluoxetine, are the most widely used antidepressants/antianxiety drugs, slowing down the rate at which serotonin, an important signaling molecule in the brain, is broken down. An SNRI, like sertraline, is a newer type of antidepressant that does the same thing for another important chemical, noradrenaline, as well as serotonin.

Major depressive disorder (MDD) is common in children and adolescents and has significant negative impacts on children's development, functioning and risk for suicide, Cooper said. According to the American Academy of Child and Adolescent Psychiatry, suicide is the third leading cause of death for 15-24 year olds and the sixth leading cause of death for 5-14 year olds.

The Vanderbilt study reviewed the medical records of 36,842 children 6 to 18 years old enrolled in Medicaid between 1995 and 2006 who were new users of one of the antidepressant medications of interest. Of those studied 415 had a medically treated suicide attempt, including four who completed suicide.

Of those included in the study, 47.4 percent had a diagnosis of MDD and one-fourth had a diagnosis of attention-deficit/hyperactivity disorder. Other common psychiatric conditions among the cohort members included conduct disorder and anxiety.

The study was not designed to compare the risk for suicide attempts for antidepressant users compared with non-users.

"These findings provide important information about the relative risks of the more recently approved antidepressants to help guide decision making by patients, their families and their providers," Cooper said. "But more research is needed to understand other safety aspects of medications used to treat children so that families and providers can make informed decisions."


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. W. O. Cooper, S. T. Callahan, A. Shintani, D. C. Fuchs, R. C. Shelton, J. A. Dudley, A. J. Graves, W. A. Ray. Antidepressants and Suicide Attempts in Children. PEDIATRICS, 2014; DOI: 10.1542/peds.2013-0923

Cite This Page:

Vanderbilt University Medical Center. "Suicide risk doesn't differ in children taking two types of commonly prescribed antidepressants." ScienceDaily. ScienceDaily, 6 January 2014. <www.sciencedaily.com/releases/2014/01/140106094021.htm>.
Vanderbilt University Medical Center. (2014, January 6). Suicide risk doesn't differ in children taking two types of commonly prescribed antidepressants. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/2014/01/140106094021.htm
Vanderbilt University Medical Center. "Suicide risk doesn't differ in children taking two types of commonly prescribed antidepressants." ScienceDaily. www.sciencedaily.com/releases/2014/01/140106094021.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins